New York State Common Retirement Fund’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

New York State Common Retirement Fund’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-18,413	Closed	-$10K	–	3222
2019 Q4	$10K	Hold	18,413	–	–	﹤0.01%	3192
2019 Q3	$70K	Buy	18,413 +3,000	+19%	+$10.8K	﹤0.01%	3110
2019 Q2	$102K	Sell	15,413 -3,125	-17%	-$11.9K	﹤0.01%	3097
2019 Q1	$66K	Buy	18,538 +12,268	+196%	+$66.6K	﹤0.01%	3034
2018 Q4	$25K	Sell	6,270 -190	-3%	-$2.43K	﹤0.01%	3147
2018 Q3	$128K	Hold	6,460	–	–	﹤0.01%	2997
2018 Q2	$205K	Buy	6,460 +4,584	+244%	+$165K	﹤0.01%	2859
2018 Q1	$69K	Hold	1,876	–	–	﹤0.01%	2999
2017 Q4	$148K	Buy	+1,876	New	+$139K	﹤0.01%	2881

New York State Common Retirement Fund's MLNT Position: Q1 2020 in Review

New York State Common Retirement Fund sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 18,413 shares — an estimated $10K sold.

New York State Common Retirement Fund first reported a position in MLNT in Q4 2017 and held it in 9 quarters. The position peaked at $205K in Q2 2018. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

New York State Common Retirement Fund reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
New York State Common Retirement Fund sold 18,413 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $10K.
New York State Common Retirement Fund first reported a position in Melinta Therapeutics, Inc. Common Stock in Q4 2017 and held it in 9 quarters.
New York State Common Retirement Fund's Melinta Therapeutics, Inc. Common Stock position peaked at $205K in Q2 2018.
2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on New York State Common Retirement Fund's 13F filing for Q1 2020, filed 6 May 2020.